Non-alcoholic fatty liver disease (NAFLD) is the predominant cause of chronic liver
conditions, and its progression is marked by evolution to non-alcoholic steatosis …

Non-alcoholic fatty liver disease (NAFLD) is a global metabolic disease with high
prevalence in both adults and children. Importantly, NAFLD is becoming the main cause of …

Objective. Berberine has been used to treat nonalcoholic steatohepatitis (NASH), which has
been addressed in many studies. In this study, we investigated the molecular pharmacology …

Aim. To assess the efficacy of berberine in the treatment of nonalcoholic fatty liver disease
through meta‐analysis. Method. We searched Embase, Pubmed, Cochrane Library, and so …

Non-alcoholic fatty liver disease (NAFLD) is a major public health problem in many
countries. Berberine (BBR) is an effective therapeutic agent in alleviating NAFLD …

Ethnopharmacological relevance Berberine (BBR) and silybin (SIY) are natural compounds
obtained from Berberidaceae members and Silybum marianum (L.) Gaertn., respectively …

Background and Aims: The disease progression of nonalcoholic fatty liver disease (NAFLD)
from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH) is driven by multiple …

Background Nonalcoholic fatty liver disease (NAFLD) is a common liver disorder that
currently lacks effective treatment. Berberine (BBR), a botanic compound isolated from …

Oxidative stress is thought to be critical for the pathogenesis of hepatic steatosis and its
progress to non-alcoholic steatohepatitis. Berberine (BBR) can improve hepatic steatosis. In …

The aim of the present study was to explore the protective effects of Berberine (BBR) against
non‑alcoholic steatohepatitis (NASH). Male 4‑week‑old C57BL/6J Apolipoprotein E‑deficient …